<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Molecular bases of regulation of cardiac muscle contractility</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2018-12-05">05 December 2018 to</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Theyencheri</forename><surname>Narayanan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Vincenzo</forename><surname>Lombardi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gabriella</forename><surname>Piazzesi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Linari</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Caremani</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matteo</forename><surname>Marcello</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">Massimo Reconditi*</orgName>
								<orgName type="institution" key="instit2">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Ilaria Morotti*</orgName>
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">University of Florence</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Molecular bases of regulation of cardiac muscle contractility</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-12-05">05 December 2018 to</date>
						</imprint>
					</monogr>
					<idno type="MD5">B4C0259AEEB53965463D1F93F4F0A392</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T15:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>LS-2867</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction:</head><p>The aim of this project is to investigate the molecular basis of heart regulation. Using X-ray diffraction on electrically paced intact trabeculae from the rat ventricle at ID02, we have shown that in the heart as in the skeletal muscle a dual filament mechanism of regulation of contraction operates: the canonical Ca 2+ -dependent thin filament activation, making the actin sites available for binding of the myosin motors, and the mechano-sensitivity in the thick filament (1,2), acting as a downstream mechanism that adapts to the load the recruitment of the myosin motors from their OFF state, in which they lie on the surface of the thick filament unable to bind actin and split ATP. In a heartbeat, unlike during skeletal muscle tetanic contraction, the rise of internal [Ca 2+ ] is transient and may not reach the level for full thin filament activation, thus the mechanical response depends on both the internal [Ca 2+ ] and the sensitivity of the thin filament to calcium (3,4), parameters that are under the control of several regulatory mechanisms among which the increase in sarcomere length (SL) (Length Dependent Activation, which is the cellular basis of the Starling Law of the heart (5)) and the phosphorylation of contractile, regulatory, and cytoskeletal proteins <ref type="bibr" target="#b3">(6)</ref><ref type="bibr">(7)</ref><ref type="bibr" target="#b4">(8)</ref>. Previous work on demembranated preparations suggested that the increase of SL and degree of phosphorylation of the Myosin Binding Protein-C (MyBP-C), an accessory protein that lies on the thick filament and can bind the thin filament with its N-terminus, can by themselves alter the regulatory state of the thick filament, switching motors ON at low Ca 2+ <ref type="bibr" target="#b5">(9)</ref>. In contrast, our recent X-ray diffraction experiments on intact trabeculae have demonstrated that inotropic interventions able to double the systolic force like increase in SL from 1.95 to 2.22 µm or addition of isoprenaline (ISO) 10 -7 M to the bathing solution (which increases the degree of phosphorylation of MyBP-C) do not affect any of the myosin based reflections related to the OFF state of the thick filament in diastole, as expected from an energetically well suited downstream mechanism as thick filament mechanosensing, which adapts the recruitment of myosin motors to the load (10). The results prove the unique effectiveness of intact trabeculae approach in structural investigations on thick filament regulation and related myopathies and suggest that in skinned preparations the membrane permeabilisation likely affects the intramolecular interactions (head-head and head-tail) and the intermolecular interactions (Myosin-MyBP-C-titin) that keep the myosin motors in the OFF state. Omecamtiv Mecarbil (OM) is a putative positive inotropic tool for treatment of systolic heart dysfunction (11,12), currently in phase-three clinical trial (13). OM binds to the catalytic domain of both α cardiac myosin (the main isoform in the mouse and rat heart and in the atrium of large mammals and human), β cardiac myosin (the main isoform in the ventricle of large mammals and human) and the slow skeletal isoform <ref type="bibr" target="#b6">(14)</ref>, increasing the affinity for actin attachment, and thus causing, in skinned myocytes, a leftward shift in the relation between force and Ca 2+ concentration (14, and our preliminary experiments). However the maximum force developed at saturating Ca 2+ is reduced to ½ that of control because myosin motors that bind OM are unable to undergo the force generating stroke (15). In LS-2867 we investigated the structural basis of the inotropic action of OM, whether it influences the regulatory state of the thick filament in diastole. Methods. The heart trabecula, dissected from the right ventricle of the rat, is mounted in a thermoregulated trough perfused with oxygenated solution (1.2 ml/min, 27°C) and attached, via titanium double hooks, to the lever arms of a strain gauge force transducer and a loudspeaker motor carried on the moveable stage of a microscope. SL is measured with a 40x dry objective and a 25x eyepiece. The length of the trabecula is adjusted to have an initial SL of ~2.1 µm (L 0 length). A pair of mylar windows is positioned close to the trabecula, about 1 mm apart, to minimize the X-ray path in the solution. The trough is sealed to prevent solution leakage and the trabecula is vertically mounted in the beam path. Trabeculae are electrically stimulated at 0.5 Hz to produce twitches. 2D X-ray patterns are collected during diastole and a the peak of the twitch both in fixed and in sarcomere length clamp conditions (16) either in control solution or in solution with 1µM OM. This OM concentration is used as it is know to potentiate the steady force attained by a skinned preparation at partial Ca 2+ activation (pCa ∼6.5, which is presumably the intracellular [Ca 2+ ] attained during the systole by an electrically paced trabecula, see also <ref type="bibr" target="#b6">(14)</ref>). A FReLoN CCD detector is placed at 31 m from the preparation to collect the first orders of the sarcomeric reflections with 1.6 ms time windows. The detector is then moved to 1.6 m to collect up to the 6th order of the myosin-based meridional reflections (5-20 ms time windows) at the same trabecula lengths as those set at 31 m. Given the long time taken by OM equilibration into the trabecula (45min), the absence of full recovery after OM washout and to avoid confounding effect of radiation damage, the data in control and in OM were collected from different trabeculae. The parameter that revealed the most effective for the normalisation of the intensity of the reflections for the different mass of individual trabeculae was the sum of the intensities of the low angle equatorials (I 1,0 + I 1,1 ). Results. Addition of 1 µM OM to the physiological solution ([Ca 2+ ] 1 mM) reduces by 30-40% the intensity of the ML1 layer line, originating from the three-stranded helical symmetry of myosin motors on the surface of the thick filament, the intensity of the meridional myosin-based reflections (M1, also contributed by the MyBP-C, M3 originating from the axial repeat of the myosin motors, M6 from the backbone periodicity) and the intensity of the meridional T1 reflection from the axial repeat of regulatory protein troponin on the thin filament. Moreover the spacing of M6, marking the extension of the thick filament, is increased by 0.3% by OM in diastole.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p>The results indicate that 1 µM OM affects the OFF state of the thick filament in diastole, indicating that ∼20% of motors are switched ON in the absence of both Ca 2+ activation of the thin filament and stress on the thick filament.</p></div>		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="middle">1</forename><surname>References</surname></persName>
		</author>
		<author>
			<persName><surname>Reconditi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PNAS</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="3240" to="3245" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">References. 1. Reconditi et al., PNAS 114:3240-5, 2017;</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Allen and Kentish</title>
		<author>
			<persName><surname>Piazzesi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="38" to="50" />
			<date type="published" when="1985">2018. 1985. 2012</date>
		</imprint>
	</monogr>
	<note>Front Physiol 4. ter Keurs J Mol Cell Cardiol</note>
	<note type="raw_reference">Piazzesi et al, Front Physiol 9:736-743, 2018. 3. Allen and Kentish, J Mol Cell Cardiol 17:821-40, 1985; 4. ter Keurs, Am J Physiol Heart Circ Physiol 302:H38-50, 2012;</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><surname>De Tombe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Cell Cardiol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="851" to="858" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Tombe et al, J Mol Cell Cardiol, 48:851-858, 2010;</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><surname>Herron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="29241" to="29249" />
			<date type="published" when="2001">2001. 2015</date>
		</imprint>
	</monogr>
	<note>Circ. Res</note>
	<note type="raw_reference">Herron et al, Circ. Res 89:1184-1190, 2001. 7. Kumar et al. J Biol Chem 290:29241-9, 2015;</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Tuning the molecular giant titin through phosphorylation: Role in health and disease</title>
		<author>
			<persName><forename type="first">Carlos</forename><surname>Hidalgo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Henk</forename><surname>Granzier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tcm.2012.10.005</idno>
	</analytic>
	<monogr>
		<title level="j">Trends in Cardiovascular Medicine</title>
		<title level="j" type="abbrev">Trends in Cardiovascular Medicine</title>
		<idno type="ISSN">1050-1738</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="165" to="171" />
			<date type="published" when="2015">2015</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Hidalgo &amp; Granzier. Trends Cardiovasc Med 23:165-71, 2015;</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Figure 7: Forest plot of sensitivity analysis on global prevalence of BORSA detection (Liu et al., 1990; Dillard et al., 1996; Huang, Yan &amp; Wu, 2000; Martineau et al., 2000; Sá-Leão et al., 2001; Nakamura et al., 2002; Balslev et al., 2005; Santhosh et al., 2008; Khorvash, Mostafavizadeh &amp; Mobasherizadeh, 2008; Ljiljana et al., 2008; Buchan &amp; Ledeboer, 2010; Bystroń et al., 2010; Leahy et al., 2011; Sieber et al., 2011; Maalej et al., 2012; Perillo et al., 2012; Al-Safaar &amp; Al-Charrakh, 2013; Tawil et al., 2013; Krupa et al., 2014, 2015; Huang et al., 2018; Argudín et al., 2018; Stańkowska et al., 2019; Zehra et al., 2020; Konstantinovski et al., 2021a, 2021b; Santos et al., 2021; Sawhney et al., 2022; Dicko et al., 2023).</title>
		<author>
			<persName><surname>Colson</surname></persName>
		</author>
		<idno type="DOI">10.7717/peerj.18604/fig-7</idno>
	</analytic>
	<monogr>
		<title level="j">Kaplinsky &amp; Mallarkey Drugs in context</title>
		<editor>
			<persName><forename type="first">Morgan</forename></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page">212518</biblScope>
			<date type="published" when="2010">2012. 2019. 2011. 2010. 2018</date>
			<publisher>PeerJ</publisher>
		</imprint>
	</monogr>
	<note>J Gen Physiol Science J Mol Cell Cardiol. ACS medicinal chemistry letters</note>
	<note type="raw_reference">Colson et al., J Mol Cell Cardiol. 53: 609-613, 2012. 10. Caremani et al., J Gen Physiol 151:53-65, 2019. 11. Malik et al. Science 331:1439-1443, 2011. 12. Morgan et al. ACS medicinal chemistry letters 1:472-477, 2010. 13. Kaplinsky &amp; Mallarkey Drugs in context 7:212518, 2018.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Figure 3: Critical appraisal about the study quality of the included randomized controlled trials (Yadav et al., 2014; Kia et al., 2015; Hazarey, Sakrikar &amp; Ganvir, 2015; Saran et al., 2018; Kuriakose et al., 2016; Thomas et al., 2017; Nosratzehi et al., 2018; Ara et al., 2018; Rai et al., 2019; Piyush et al., 2019; Kia et al., 2020; Nerkar Rajbhoj et al., 2021; Srivastava et al., 2021; Adhikari et al., 2022; Upadhyay et al., 2023; Namratha et al., 2023).</title>
		<author>
			<persName><surname>Nagy</surname></persName>
		</author>
		<idno type="DOI">10.7717/peerj.18492/fig-3</idno>
	</analytic>
	<monogr>
		<title level="m">Woody et al. Nat comm 9</title>
		<imprint>
			<publisher>PeerJ</publisher>
			<date type="published" when="2015">2015. 2018. 2016</date>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="3675" to="3680" />
		</imprint>
	</monogr>
	<note>PNAS</note>
	<note type="raw_reference">Nagy et al, Br J Pharmacol 172:4506-4518, 2015. 15. Woody et al. Nat comm 9.3838, 2018. 16. Caremani et al. PNAS 113:3675-3680, 2016.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
